Airlift Bioreactors Market

An airlift bioreactor is a type of bioreactor in which the contents are mixed using aeration. Airlift bioreactors are often used when a high surface area to volume ratio is needed, such as when making microorganisms or treating wastewater. Batch or continuous-flow airlift bioreactors are available. The contents of a batch system are mixed and then allowed to settle before being discharged. The contents of a continuous system are constantly mixed and discharged.

The global airlift bioreactors market was worth $XX million in 2018 and is expected to grow at an XX% CAGR to $XX million by 2031. Airlift bioreactors are used in aerobic or anaerobic digestion, which is the decomposition of organic matter in the presence of oxygen by microorganisms to produce energy. The machine works by moving air through the liquid medium. This gives the microorganisms oxygen and helps keep them in suspension.

The market has been divided into several major regions: North America, Europe, Asia-Pacific, and South America. In the regional segment, there will be in-depth analyses of major countries like the United States, Germany, the United Kingdom, Italy, France, China, Japan, South Korea, Southeast Asia, and India.

Eppendorf AG, Sartorius Stedim Biotech S.A., Merck KGaA (MilliporeSigma), Danaher Corporation (Pall Corporation), GE Healthcare Life Sciences, Applikon Biotechnology BV, Hettich Instruments L.P., IKA-Werke GmbH & Co. KG, Thermo Fisher Scientific Inc., and BIOTEK ELIX Corporation are some of the key players in the airlift bioreactors market.